[{"NetIncomeLoss_1_Q2_USD":207000000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":null,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":989000000.0,"OtherInventoryInTransit_0_Q2_USD":164000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2446000000.0,"IncreaseDecreaseInOperatingCapital_2_Q2_USD":1679000000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":205000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":2223000000.0,"LiabilitiesNoncurrent_0_Q2_USD":25193000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":13000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-47000000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RepaymentsOfLongTermDebt_2_Q2_USD":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":242000000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":532000000.0,"DepreciationAndAmortization_2_Q2_USD":681000000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":null,"ProceedsFromDivestitureOfBusinesses_2_Q2_USD":254000000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":196000000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":36000000.0,"CommonStockSharesIssued_0_Q2_shares":1209000000.0,"TreasuryStockValue_0_Q2_USD":4128000000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q2_USD":25600000000.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":1737000000.0,"SellingAndMarketingExpense_1_Q2_USD":615000000.0,"SellingAndMarketingExpense_2_Q2_USD":1200000000.0,"TreasuryStockShares_0_Q2_shares":106000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":14000000.0,"FairValueNetAssetLiability_0_Q2_USD":2277000000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":4141000000.0,"RestructuringCharges_1_Q2_USD":-13000000.0,"RestructuringCharges_2_Q2_USD":69000000.0,"FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_2_Q2_USD":-9000000.0,"LongTermDebtCurrent_0_Q2_USD":3507000000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":29000000.0,"AssetsCurrent_0_Q2_USD":12822000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":2037000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":21000000.0,"Liabilities_0_Q2_USD":37884000000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":153000000.0,"PrepaidExpenseCurrent_0_Q2_USD":1022000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1109000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1108000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-49000000.0,"AdjustmentForAmortization_1_Q2_USD":173000000.0,"AdjustmentForAmortization_2_Q2_USD":414000000.0,"MinorityInterest_0_Q2_USD":987000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":4488000000.0,"EarningsPerShareBasic_1_Q2_USD":0.19,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":12390000000.0,"ValuationAllowancesAndReservesDeductions_2_Q2_USD":7209000000.0,"DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_0_Q2_USD":9000000.0,"OtherOperatingIncomeExpenseNet_1_Q2_USD":43000000.0,"OtherOperatingIncomeExpenseNet_2_Q2_USD":48000000.0,"DerivativeLossOnDerivative_2_Q2_USD":493000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":308000000.0,"EarningsPerShareBasic_2_Q2_USD":0.26,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":642000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":98000000.0,"NumberOfReportableSegments_2_Q2_Segment":3.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":444000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2436000000.0,"OtherAssetsNoncurrent_0_Q2_USD":530000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":173000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":414000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":295000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":238000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":159000000.0,"OtherAssetsCurrent_0_Q2_USD":484000000.0,"SeniorNotes_0_Q2_USD":25183000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":-19000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-16000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-494000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":248000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":501000000.0,"CommonStockValue_0_Q2_USD":57000000.0,"AssetsFairValueAdjustment_2_Q2_USD":-42000000.0,"DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_0_Q2_USD":55000000.0,"Assets_0_Q2_USD":49195000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-115000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1101000000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1333000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-187000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":79000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-130000000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":4524000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":29000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1103000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":60000000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":-7000000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":11000000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":14000000.0,"DebtInstrumentFairValue_0_Q2_USD":24997000000.0,"EarningsPerShareDiluted_1_Q2_USD":0.19,"EarningsPerShareDiluted_2_Q2_USD":0.26,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q2_USD":932000000.0,"Goodwill_0_Q2_USD":20421000000.0,"AssetImpairmentCharges_2_Q2_USD":354000000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_2_Q2_USD":274000000.0,"LiabilitiesCurrent_0_Q2_USD":12691000000.0,"NetIncomeLoss_2_Q2_USD":284000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":6127000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-3000000.0,"OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_1_Q2_USD":1000000.0,"OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_2_Q2_USD":1000000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q2_USD":2300000000.0,"LongTermNotesAndLoans_0_Q2_USD":21602000000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q2_USD":195000000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":8120000000.0,"AccrualForEnvironmentalLossContingencies_0_Q2_USD":300000.0,"AdditionalPaidInCapital_0_Q2_USD":27503000000.0,"GrossProfit_1_Q2_USD":1873000000.0,"GrossProfit_2_Q2_USD":3750000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":2436000000.0,"NonoperatingIncomeExpense_1_Q2_USD":-274000000.0,"NonoperatingIncomeExpense_2_Q2_USD":-564000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":11311000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":191000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":259000000.0,"DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0_Q2_USD":7000000.0,"OperatingIncomeLoss_1_Q2_USD":582000000.0,"OperatingIncomeLoss_2_Q2_USD":1015000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q2_USD":32000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":80000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":3910000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":7892000000.0,"CommonStockSharesAuthorized_0_Q2_shares":2495000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":451000000.0,"LitigationSettlementExpense_1_Q2_USD":6000000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_1_Q2_USD":-7000000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_2_Q2_USD":-14000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_CHF":0.1,"DeferredIncomeTaxAssetsNet_0_Q2_USD":645000000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":531000000.0,"ShareBasedCompensation_2_Q2_USD":60000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":87000000.0,"LitigationSettlementExpense_2_Q2_USD":110000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-10662000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":308000000.0,"InventoryNet_0_Q2_USD":4362000000.0,"DebtCurrent_0_Q2_USD":3530000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":120000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":263000000.0,"StockholdersEquity_0_Q2_USD":10324000000.0,"OtherLiabilitiesCurrent_0_Q2_USD":838000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2215000000.0,"ProfitLoss_1_Q2_USD":221000000.0,"AccountsPayableTradeCurrent_0_Q2_USD":1551000000.0,"ProfitLoss_2_Q2_USD":306000000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.26,"DeferredFinanceCostsNoncurrentNet_0_Q2_USD":75000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":511000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":49195000000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":20510000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":204000000.0,"RestructuringReserve_0_Q2_USD":127000000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.19,"EntityCommonStockSharesOutstanding_0_Q2_shares":1102885659.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210728"}]